A randomised study comparing granulocyte-coiony stimulating factor (G-CSF) with G-CSF plus thymostimulin in the treatment of haematological toxicity in patients with advanced breast cancer after high dose mitoxantrone therapy-Reference-Cited by-同舟云学术

A randomised study comparing granulocyte-coiony stimulating factor (G-CSF) with G-CSF plus thymostimulin in the treatment of haematological toxicity in patients with advanced breast cancer after high dose mitoxantrone therapy

Published:1996-01 Issue:1 Volume:32 Page:52-56
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Sanchiz F.,Milla A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Can hematopoietic growth factors be used to improve the success of cytotoxic chemotherapy?;Bronchud;Anti-cancer Drugs,1993

2. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo;Lord,1989

3. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer;Crawford;N Engl J Med,1991

4. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy;Trillet-Lenoir;Eur J Cancer,1993

5. Granulocyte-colony stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial;Pettengell;Blood,1992

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymic peptides for treatment of cancer patients;Cochrane Database of Systematic Reviews;2011-02-16

2. A Systematic Overview of Chemotherapy Effects in Breast Cancer;Acta Oncologica;2001-03-01

3. Intensification of Adjuvant Chemotherapy: 5-Year Results of a Randomized Trial Comparing Conventional Doxorubicin and Cyclophosphamide With High-Dose Mitoxantrone and Cyclophosphamide With Filgrastim in Operable Breast Cancer With 10 or More Involved Axillary Nodes;Journal of Clinical Oncology;2001-02-01